XK
MRTX

Xact Kapitalforvaltning’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Xact Kapitalforvaltning’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$461K Hold
6,000
– – 0.01% 795
2019
Q4 		$773K Hold
6,000
– – 0.01% 739
2019
Q3 		$467K Buy
6,000
+1,400
+30% +$131K 0.01% 946
2019
Q2 		$474K Buy
4,600
+1,400
+44% +$109K 0.01% 953
2019
Q1 		$235K Buy
+3,200
New +$218K 0.01% 1339

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Xact Kapitalforvaltning's MRTX Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Mirati Therapeutics, Inc. Common Stock (MRTX) position steady in Q1 2020 at 6,000 shares worth $461K. The position accounts for 0.01% of the portfolio, ranked #795.

Xact Kapitalforvaltning first reported a position in MRTX in Q1 2019 and has held it in 5 quarters since. The position peaked at $773K in Q4 2019. 173 funds tracked by Wall St. Rank hold MRTX as of Q1 2020.

  • Xact Kapitalforvaltning held 6,000 shares of Mirati Therapeutics, Inc. Common Stock worth $461K as of Q1 2020.
  • Xact Kapitalforvaltning left its Mirati Therapeutics, Inc. Common Stock share count unchanged in Q1 2020.
  • Mirati Therapeutics, Inc. Common Stock made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #795 holding.
  • Xact Kapitalforvaltning first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2019 and has held it in 5 quarters since.
  • Xact Kapitalforvaltning's Mirati Therapeutics, Inc. Common Stock position peaked at $773K in Q4 2019.
  • 173 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.